Press Releases for the Psychedelics Industry | Page 19 of 37

Psychedelics News

Press Releases

2 Mar 2021

Psyched Wellness Provides Update on Pre-Clinical Trial of Its Muscimol Extract AME-1

Toronto, Ontario–(Newsfile Corp....

By Microdose

Press Releases

2 Mar 2021

PsyBio Announces Second Quarter Financial Results of Leo Acquisition Corp.

TORONTO, March 01, 2021 (GLOBE NEWSWIRE) — PsyBio Therapeutics Corp....

By Microdose

Press Releases

1 Mar 2021

Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

DENVER, March 01, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma company in the life sciences category committed...

By Microdose

Press Releases

26 Feb 2021

Ehave Inc. Reaches Milestone; Ketamine IV Therapy Provider KetaDASH to Launch Beta in Second Quarter 2021

MIAMI, Feb....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

26 Feb 2021

Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request

TORONTO, Feb....

By Microdose

Press Releases

26 Feb 2021

Havn Life Sciences to Host Investor Webcast on March 3, 2021

Attendees will have the opportunity to get the latest updates and participate in Q & A with Havn Life CEO Tim Moore Vancouver, BC – Havn Life Sciences Inc....

By Microdose

Press Releases

25 Feb 2021

Field Trip Health Announces $50 Million Bought Deal Offering of Common Shares

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES....

By Microdose

Press Releases

25 Feb 2021

REPEAT – Pure Extracts Submits Multiple SKUs to Health Canada for Approval

VANCOUVER, British Columbia, Feb....

By Microdose

Press Releases

25 Feb 2021

PsyBio Therapeutics Corp. Begins Trading on the TSX Venture Exchange

TORONTO, Feb....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result